Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.72
+0.16 (1.10%)
Mar 6, 2026, 10:50 AM EST - Market open
Vor Biopharma Employees
Vor Biopharma had 159 employees as of December 31, 2024. The number of employees decreased by 9 or -5.36% compared to the previous year.
Employees
159
Change (1Y)
-9
Growth (1Y)
-5.36%
Revenue / Employee
n/a
Profits / Employee
-$15,906,175
Market Cap
611.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159 | -9 | -5.36% |
| Dec 31, 2023 | 168 | 35 | 26.32% |
| Dec 31, 2022 | 133 | -2 | -1.48% |
| Dec 31, 2021 | 135 | 47 | 53.41% |
| Dec 31, 2020 | 88 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| Alpha Tau Medical | 125 |
| Ocugen | 95 |
| enGene Holdings | 82 |
| Larimar Therapeutics | 65 |
| Design Therapeutics | 55 |
| Zura Bio | 30 |
VOR News
- 11 hours ago - Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 11 days ago - Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference - GlobeNewsWire
- 2 months ago - Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Vor Bio Appoints RA Capital's Andrew Levin, M.D., Ph.D., and Forbion's Wouter Joustra to Board of Directors - GlobeNewsWire
- 2 months ago - Vor Bio Announces $150 Million Private Placement - GlobeNewsWire
- 4 months ago - Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial - Benzinga
- 4 months ago - Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock - GlobeNewsWire